Zions Bancorporation, N.A. Novo Cure LTD Transaction History

Zions Bancorporation, N.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$40.29 - $82.51 $282 - $577	7 Added 18.92%	44 $1,000
Q3 2022 Nov 08, 2022	SELL	$67.99 - $89.57 $1,699 - $2,239	-25 Reduced 40.32%	37 $3,000
Q2 2022 Aug 05, 2022	SELL	$56.6 - $89.9 $2,150 - $3,416	-38 Reduced 38.0%	62 $4,000
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $4,751 - $6,677	79 Added 376.19%	100 $8,000
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $1,426 - $2,317	-19 Reduced 47.5%	21 $2,000
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $929 - $1,556	8 Added 25.0%	40 $5,000
Q2 2021 Aug 11, 2021	BUY	$130.4 - $225.58 $1,956 - $3,383	15 Added 88.24%	32 $7,000
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $2,109 - $3,232	17 New	17 $2,000
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $10,259 - $18,014	-321 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $9,219 - $16,894	321 New	321 $11,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.